Wealthcare Advisory Partners LLC Novo Cure LTD Transaction History

Wealthcare Advisory Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $63,504 - $109,857	-487 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$124.11 - $190.17 $60,441 - $92,612	487 New	487 $64,000
Q2 2020 Jul 29, 2020	SELL	$57.2 - $74.41 $23,852 - $31,028	-417 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$57.05 - $95.75 $8,956 - $15,032	157 Added 60.38%	417 $28,000
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $5,161 - $8,320	260 New	260 $8,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.